We look at the first systematic review of an ever-evolving diagnostic access pathway, performance-based risk-sharing agreements, in the United States. In our next blogpost, we will review the same trends in diagnostic patient access in Europe.
The Swiss medical tariff, TARMED is being updated to a new version, the TARDOC. However, the controversial process has taken longer than expected. What is going on?